Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma

British Journal of Haematology

Volumn 98, Issue 2, 1997, Pages 488-491

  Probst Kepper, Michael ^a   Schrader, Andres ^a   Buer, Jan ^a   Grosse, Jens ^a   Volkenandt, Matthias ^c   Illiger, Hans Joachim ^b   Metzner, Bernd ^b   Kadar, Janosch ^a   Duensing, Stefan ^a   Hertenstein, Bernd ^a   Ganser, Arnold ^a   Atzpodien, Jens ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Autologous transplantation; Malignant melanoma; Peripheral blood stem cells; RT PCR; Tyrosinase mRNA

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BETA INTERFERON; CARBOPLATIN; CARMUSTINE; CISPLATIN; DACARBAZINE; FOTEMUSTINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; MELPHALAN; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MELANOCYTE; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 8544277978     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.1963015.x     Document Type: Article

References (11)

1. Ariel, I.M. & Pack, G.T. (1962) Treatment of disseminated melanoma with phenylalanine mustard (melphalan) and autologous bone marrow transplants. Surgery, 51, 582-587.
2. Brasseur, F., Rimoldi, D., Liénard, D., Lethé, B., Carrel, S., Arienti, F., Suter, L., Vanwijck, R., Bouriond, A., Humblet, Y., Vacca, A., Conese, M., Lahaye, T., Degiovanni, G., Deraemaecker, R., Beaudin, M., Sastre, X., Salmon, E., Dréno, B., Jaeger, E., Knuth, A., Chevreau, C., Suciu, S., Lachapelle, J-M., Pauillart, P., Parmiani, G., Lejeune, F., Cerottini, J-C., Boon, T. & Marchand, M. (1995) Expression of MAGE genes in primary and metastatic cutaneous melanoma. International Journal of Cancer, 63, 375-380.
3. Brenner, M.K., Rill, D.R., Moen, R.C., Krance, R.A., Mirro, J., Anderson, W.F. & Ihle, J.N. (1995) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet, 341, 85-86.
4. + blood cells. British Journal of Haematology, 94, 716-721.
5. Henry, J.M., Sykes, P.J., Brisco, M.J., To, L.B., Juttner, C.A. & Morley, A.A. (1996) Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests. British Journal of Haematology, 92, 614-614.
6. Herzig, R.H. (1995) Dose-intensive therapy for advanced melanoma. High-dose Cancer Therapy, 2nd edn (ed. by L. O. Armitage and K. H. Antman), pp. 875-878. Williams & Wilkins, Baltimore.
7. Hoon, D.S., Wang, Y., Dale, P.S., Conrad, A.J., Schmid, P., Garrison, D., Kuo, C., Foshag, L.J., Nizze, A.J. & Morton, D.L. (1995) Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. Journal of Clinical Oncology, 13, 2109-2116.
8. Keilholz, U. (1996) Diagnostic PCR in melanoma, methods and quality assurance. European Journal of Cancer, 32A, 1661-1665.
9. Kunter, U., Buer, J., Probst, M., Duensing, S., Dallmann, I., Grosse, J., Kirchner, H., Schluepen, K.M., Volkenandt, M., Ganser, A. & Atzpodien, J. (1996) Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. Journal of the National Cancer Institute, 88, 590-594.
10. Meisenberg, B. (1996) High-dose chemotherapy and autologous stem cell support for patients with malignant melanoma. Bone Marrow Transplantation, 17, 905-906.
11. Smith, B., Selby, P., Southgate, J., Pittman, K., Bradley, C. & Blair, G.E. (1941) Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet, 338, 1227-1229.